Measles Vaccines Designed for Enhanced CD8
Animals
Antigen Presentation
/ immunology
Antigens, Neoplasm
/ immunology
CD8-Positive T-Lymphocytes
/ immunology
Cell Line
Epitopes, T-Lymphocyte
/ genetics
Genetic Vectors
Interferon-gamma
/ immunology
Interferon-gamma Release Tests
Lymphocyte Activation
Measles Vaccine
/ genetics
Mice
Mice, Inbred C57BL
Ovalbumin
/ genetics
Proof of Concept Study
T-Lymphocytes, Cytotoxic
/ immunology
Vaccines, Synthetic
/ immunology
CD8+ T cell activation
T cell priming
cancer immunotherapy
measles
oncolytic virus
vaccination
Journal
Viruses
ISSN: 1999-4915
Titre abrégé: Viruses
Pays: Switzerland
ID NLM: 101509722
Informations de publication
Date de publication:
21 02 2020
21 02 2020
Historique:
received:
20
12
2019
revised:
16
02
2020
accepted:
19
02
2020
entrez:
27
2
2020
pubmed:
27
2
2020
medline:
20
2
2021
Statut:
epublish
Résumé
Priming and activation of CD8
Identifiants
pubmed: 32098134
pii: v12020242
doi: 10.3390/v12020242
pmc: PMC7077255
pii:
doi:
Substances chimiques
Antigens, Neoplasm
0
Epitopes, T-Lymphocyte
0
Measles Vaccine
0
Vaccines, Synthetic
0
Interferon-gamma
82115-62-6
Ovalbumin
9006-59-1
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Références
J Immunol. 2016 Jun 1;196(11):4587-95
pubmed: 27183620
Cell Microbiol. 2011 Jul;13(7):925-33
pubmed: 21501363
Cancer Immunol Res. 2018 Oct;6(10):1161-1173
pubmed: 30209061
Mol Ther. 2012 Jun;20(6):1139-47
pubmed: 22334023
Clin Cancer Res. 2018 May 1;24(9):2128-2137
pubmed: 29437789
J Virol. 2015 Nov;89(22):11654-67
pubmed: 26355094
Viruses. 2019 Oct 03;11(10):
pubmed: 31623390
Hum Vaccin Immunother. 2016 Jul 2;12(7):1678-89
pubmed: 26901482
Vaccine. 2012 Sep 7;30(41):5991-8
pubmed: 22732429
Cancer Res. 2008 Jun 15;68(12):4882-92
pubmed: 18559536
Mol Ther. 2011 Oct;19(10):1813-20
pubmed: 21610701
Cold Spring Harb Perspect Med. 2011 Sep;1(1):a007252
pubmed: 22229122
Viruses. 2019 Jul 27;11(8):
pubmed: 31357579
Cancer Immunol Immunother. 2018 Jun;67(6):999-1009
pubmed: 29487978
EMBO J. 1995 Dec 1;14(23):5773-84
pubmed: 8846771
Vaccine. 2003 Sep 8;21(25-26):3946-53
pubmed: 12922130
Cancer Res. 2003 Oct 1;63(19):6463-8
pubmed: 14559838
Clin Cancer Res. 2013 Mar 1;19(5):1147-58
pubmed: 23339127
Immunity. 2006 Oct;25(4):533-43
pubmed: 17046682
Immunol Lett. 2006 Sep 15;107(1):41-9
pubmed: 16949679
Oncolytic Virother. 2018 Nov 26;7:117-128
pubmed: 30538968
PLoS One. 2011;6(9):e24135
pubmed: 21915289
J Immunol. 1997 Dec 15;159(12):6037-43
pubmed: 9550402
Mol Ther. 2014 Feb;22(2):420-429
pubmed: 24322333
Nat Rev Immunol. 2015 Jul;15(7):405-14
pubmed: 26027717
Curr Top Microbiol Immunol. 2009;329:129-62
pubmed: 19198565
Nat Biotechnol. 2012 Mar 18;30(4):337-43
pubmed: 22426030
Virus Genes. 2017 Oct;53(5):733-740
pubmed: 28710608
Sci Transl Med. 2019 Oct 2;11(512):
pubmed: 31578242
J Immunol. 2001 May 1;166(9):5366-73
pubmed: 11313372
Cancer Gene Ther. 2010 Aug;17(8):550-8
pubmed: 20379224
PLoS One. 2015 Sep 23;10(9):e0138458
pubmed: 26397953
Expert Opin Biol Ther. 2017 Mar;17(3):353-363
pubmed: 28129716
NPJ Vaccines. 2019 Feb 27;4:12
pubmed: 30820355
J Immunother Cancer. 2019 Jul 17;7(1):189
pubmed: 31315674
J Virol. 2006 Jun;80(12):5708-15
pubmed: 16731909
Methods Mol Biol. 2020;2058:111-126
pubmed: 31486034
Proc Natl Acad Sci U S A. 2006 Jan 24;103(4):994-9
pubmed: 16418289
Lancet. 2019 Dec 22;392(10165):2718-2727
pubmed: 30409443
Sci Rep. 2017 Dec 4;7(1):16892
pubmed: 29203786
J Immunol. 1996 Oct 15;157(8):3242-9
pubmed: 8871618
Nature. 1991 May 23;351(6324):290-6
pubmed: 1709722
Hum Gene Ther. 2013 Jul;24(7):644-54
pubmed: 23642239
Oncoimmunology. 2018 Aug 27;7(12):e1503032
pubmed: 30524901
J Gen Virol. 2020 Feb 13;:
pubmed: 32053093
Cancer Immunol Res. 2017 Oct;5(10):847-859
pubmed: 28912369
J Virol. 2004 Jan;78(1):146-57
pubmed: 14671096
Mol Ther. 2014 Nov;22(11):1949-59
pubmed: 25156126
PLoS One. 2015 Mar 18;10(3):e0116412
pubmed: 25786238
Nat Med. 2011 Jun 19;17(7):854-9
pubmed: 21685898
Cochrane Database Syst Rev. 2012 Feb 15;(2):CD004407
pubmed: 22336803
J Gen Virol. 2017 Sep;98(9):2248-2257
pubmed: 28809150
J Virol. 1999 Jun;73(6):4823-8
pubmed: 10233943
J Virol. 1993 Aug;67(8):4822-30
pubmed: 8392616
Virology. 1987 Oct;160(2):523-6
pubmed: 3660593
Mol Ther. 2018 Apr 4;26(4):1008-1019
pubmed: 29478729
Viral Immunol. 2018 Mar;31(2):86-95
pubmed: 29256824
Cancer Cell. 2018 Apr 9;33(4):599-605
pubmed: 29634947
Vaccine. 2008 Apr 16;26(17):2164-74
pubmed: 18346823
J Exp Med. 1997 Feb 3;185(3):453-9
pubmed: 9053445
J Vis Exp. 2019 Jan 7;(143):
pubmed: 30663684
Proc Natl Acad Sci U S A. 1998 Oct 13;95(21):12504-9
pubmed: 9770515
Oncoimmunology. 2018 Sep 19;8(1):e1512329
pubmed: 30546947
Oncoimmunology. 2017 Jan 31;6(4):e1285992
pubmed: 28507792
J Virol. 2015 Feb;89(4):2192-200
pubmed: 25473055
Oncoimmunology. 2018 Mar 27;7(7):e1445459
pubmed: 29900060
Nat Rev Immunol. 2018 Oct;18(10):635-647
pubmed: 30057419
J Immunol. 2008 Aug 1;181(3):2124-33
pubmed: 18641351
J Mol Biol. 1999 Mar 5;286(4):1251-65
pubmed: 10047495
J Virol. 1997 Nov;71(11):8497-503
pubmed: 9343207